Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results
Charles C. Wykoff, Vrinda Hershberger, David Eichenbaum, Erin C. Henry, Husam S. Younis, Priya Chandra, Nancy Yuan, Mark J. Solloway, Alex M. DePaoli
Topics & Concepts
MedicineChoroidal neovascularizationVisual acuityPharmacokineticsMacular degenerationAdverse effectTolerabilityOphthalmologyLesionPharmacodynamicsSurgeryInternal medicineRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Development and Disorders